NCT05195528Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Study sponsor: Phathom Pharmaceuticals, Inc. · PHAT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-11-21Actual
Enrollment · participants776Actual
Source updated2023-12-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview